GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

enfortumab vedotin   Click here for help

GtoPdb Ligand ID: 10738

Synonyms: ASG-22CE | enfortumab vedotin-ejfv | Padcev®
Approved drug
enfortumab vedotin is an approved drug (FDA (2019), EMA (2022))
Compound class: Antibody
Comment: Enfortumab vedotin is an anti-Nectin 4 monoclonal antibody-drug conjugate [3]. The toxic payload is monomethyl auristatin E (MMAE; PubChem CID 11542188). It exhibits potent efficacy in multiple preclinical cancer models [1].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2024)  |  EU EMA (2022)  |  US FDA (2019)
International Nonproprietary Names Click here for help
INN number INN
9821 enfortumab vedotin
Synonyms Click here for help
ASG-22CE | enfortumab vedotin-ejfv | Padcev®
Database Links Click here for help
GtoPdb PubChem SID 405067331
Search PubMed clinical trials enfortumab vedotin
Search PubMed titles enfortumab vedotin
Search PubMed titles/abstracts enfortumab vedotin